Synthesis, In Silico Molecular Docking Modeling and Pharmacophore Mapping of (E)-3-(4-Hydroxy-2,6-Dimethoxyphenyl)-1-Phenylprop-2-en-1-One as Potential New Inhibitor of Microsomal Prostaglandin E2 Synthase-1

Article Preview

Abstract:

The discovery of potent anti-inflammatory agents through inhibition of prostaglandin E2 (PGE2) via microsomal prostaglandin E2 synthase-1 (mPGES-1) blocking has been proven to be an important game changer in pharmaceutical industry in recent years. In this study, new chalcone derivative has been successfully synthesized via Claisen-Schmidt condensation reaction. The compound was then docked into mPGES-1 active site to predict anti-inflammatory properties through ligand-enzyme interaction investigation. The data collected from in silico molecular docking simulation and pharmacophore modeling studies provide important insight on the molecular conformation and further shed light towards structural modification of the future novel mPGES-1 inhibitor.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

247-252

Citation:

Online since:

March 2020

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2020 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li Y., Wang X., Zhao, L. Inflammatory responses and inflammation-associated diseases in organs, Oncotarget, (2018) 9(6), 7204–7218.

DOI: 10.18632/oncotarget.23208

Google Scholar

[2] FitzGerald G.A., Coxibs and cardiovascular diseases, N. Eng. J. Med. (2004) 351, 1709-1711.

Google Scholar

[3] Mitchell J.A., Warner T.D., COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nat. Rev. Drug Discov., (2006) 75-86.

DOI: 10.1038/nrd1929

Google Scholar

[4] Bishop-Bailey D., Mitchell J.A., Warner T.D., COX-2 in Cardiovascular Disease. (2006) 26:956–958.

Google Scholar

[5] Majed, B. H., & Khalil, R. A. (2012). Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacological reviews, 64(3), 540–582.

DOI: 10.1124/pr.111.004770

Google Scholar

[6] Elvira E., Josep Q. R., Xavier G., Antoni B. M., and Rosa M. L., (2019) In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice. Journal of Natural Products 82 (2), 177-182.

DOI: 10.1021/acs.jnatprod.8b00366

Google Scholar

[7] Hosseinzade, A., Sadeghi, O., Naghdipour Biregani, A., Soukhtehzari, S., Brandt, G. S., & Esmaillzadeh, A. (2019). Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+ Regulatory Cells Through Suppression of mTOR Pathway Signaling Activity Frontiers in immunology, 10, 51.

DOI: 10.3389/fimmu.2019.00051

Google Scholar

[8] Lee H.H, Moon Y.H, Shin J.S, Lee J.H, Kim T.W, Jang C.Y, Park C., Lee J., Kim Y., Kim Y., Werz O., Park B.Y, Lee J.Y, Lee K.T, (2019) A novel mPGES-1 inhibitor alleviates inflammatory responses by downregulating PGE2 in experimental models, Prostaglandins & Other Lipid Mediators,144, 1098-8823.

DOI: 10.1016/j.prostaglandins.2019.106347

Google Scholar

[9] Rullah K., Aluwi M.F.F.M, Yamin B. M., Bahari M. N. A., Wei L. S., Ahmad S., Abas F., Ismail N. H., Jantan I., Wai L. K. (2014) Inhibition of prostaglandin E2 production by synthetic minor prenylated chalcones and flavonoids: Synthesis, biological activity, crystal structure, and in silico evaluation, Bioorganic & Medicinal Chemistry Letters, 24 (16), 3826-3834.

DOI: 10.1016/j.bmcl.2014.06.061

Google Scholar

[10] Luz J.G. , Antonysamy S., Kuklish S.L., Condon B., Lee M.R., Allison D., Yu X.P., Chandrasekhar S., Backer R., Zhang A., Russell M., Chang S.S., Harvey A., Sloan A.V., Fisher M.J., (2015). Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. Journal of Medicinal Chemistry. 58(11), 4727-37.

DOI: 10.1021/acs.jmedchem.5b00330

Google Scholar